Anaesthesia related outcomes of children with congenital heart disease undergoing surgical or nonsurgical cardiac procedures: a multicenter, observational trial

Anaesthesia related outcomes of children with congenital heart disease undergoing surgical or nonsurgical cardiac procedures: a multicenter, observational trial - AROUND TRIAL

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00038695

Enrollment

1000

Registered

2025-12-22

Start date

2026-04-01

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Q24

Interventions

Group 1: A multicenter, prospective observational study is planned to answer various current questions regarding anesthesia-related target parameters in children with congenital heart defects who are

the target is approximately 100 children enrolled per center (approximately 1,000 in total).

Eligibility

Sex/Gender

All

Age

No minimum to 17 Years

Inclusion criteria

Inclusion criteria: All children undergoing anesthesia for surgical or interventional procedures are included. The data consists of routine care data that is entered into the database in anonymized form.

Exclusion criteria

Exclusion criteria: Age 18 years or older.

Design outcomes

Primary

Measure	Time frame
Anesthesia related complications during heart surgery or intervention in the cardiac catheterization laboratory.	—

Secondary

Measure	Time frame
Secondary endpoints only in children undergoing cardiac surgery: Secondary question 1: - Intraoperative anticoagulation therapy (what, how much, how measured?) - Postoperative blood loss, incidence of thrombosis, cumulative heparin administration in the first 24 hours postoperatively, reoperations due to bleeding Secondary question 2: - Intraoperative analgesia regimen (What? How much?) - Highest pain intensity in the first 24 hours postoperatively, opioid-related complications (nausea, vomiting, sedation) Secondary question 3: - Incidence of extubation in the operating room - Mortality, reintubation, noninvasive respiratory support, pleural drainage losses, mean maximum vasoactive inotropic score in the first 24 hours in the intensive care unit (maximum doses of catecholamines required in the intensive care unit in the first 24 hours), length of stay in the intensive care unit	—

Measure

Time frame

Secondary endpoints only in children undergoing cardiac surgery: Secondary question 1: - Intraoperative anticoagulation therapy (what, how much, how measured?) - Postoperative blood loss, incidence of thrombosis, cumulative heparin administration in the first 24 hours postoperatively, reoperations due to bleeding Secondary question 2: - Intraoperative analgesia regimen (What? How much?) - Highest pain intensity in the first 24 hours postoperatively, opioid-related complications (nausea, vomiting, sedation) Secondary question 3: - Incidence of extubation in the operating room - Mortality, reintubation, noninvasive respiratory support, pleural drainage losses, mean maximum vasoactive inotropic score in the first 24 hours in the intensive care unit (maximum doses of catecholamines required in the intensive care unit in the first 24 hours), length of stay in the intensive care unit

—

Countries

Germany

Contacts

Public ContactAlexander Schnabel

Universitätsklinikum Münster, Klinik für Anästhesiologie, operative Intensivmedizin und Schmerztherapie

Alexander.Schnabel@ukmuenster.de+49 251 83-47255

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026